Safety of long term biologic therapy in rheumatologic patients with a previously resolved HBV infection

MLA

Avolio, Alfonso Wolfango, et al. Safety of Long Term Biologic Therapy in Rheumatologic Patients with a Previously Resolved HBV Infection. Jan. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2601..31d5303af03cc87d5f2cbff6af2415dc&authtype=sso&custid=ns315887.

APA

Avolio, A. W., Barone, M., Notarnicola, A., Lopalco, G., Viggiani, M., Sebastiani, F., Covelli, M., Iannone, F., Di Leo, A., Cantarini, L., & Lapadula, G. (2015). Safety of long term biologic therapy in rheumatologic patients with a previously resolved HBV infection.

Chicago

Avolio, Alfonso Wolfango, M Barone, A Notarnicola, G Lopalco, Mt Viggiani, F Sebastiani, M Covelli, et al. 2015. “Safety of Long Term Biologic Therapy in Rheumatologic Patients with a Previously Resolved HBV Infection,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2601..31d5303af03cc87d5f2cbff6af2415dc&authtype=sso&custid=ns315887.